508,509 Additionally, the plasticity of CSCs and their dynamic interaction with niche factors can lead to divergent drug responses that are not accurately predicted in conventional models
So, for example, its not surprising that sleep apnea or fatty liver disease is helped by these medications after all, weight loss can reverse both in a large proportion of patients
Overweight or obese people can become leptin-resistant, meaning the brain does not respond as sensitively to leptin
Well reference scientific studies (with handy links and citations) to separate hype from reality
In this respect, GLP-1 receptor agonists represent disease-modifying agents with implications that extend well beyond the management of weight and glycaemia
l-karnitin ya yakmn hzlandrr m